title: [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
abstract: The report discusses the results of treatment of 54 patients (aged 2-14) with stage IIIA Hodgkin's disease. Radiotherapy was followed by relapse-free period in 60.6% only, although 5-year survival rate was rather high (90.9%). In the chemoradiation treatment group the said rates were 92.3 and 100%, respectively.
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Rol' luchevoĭ terapii v lechenii limfogranulematoza IIIA stadii u deteĭ.